Mycosis fungoides: Difference between revisions
Jump to navigation
Jump to search
Varun Kumar (talk | contribs) No edit summary |
|||
Line 48: | Line 48: | ||
==Resources== | ==Resources== | ||
* [http://www.clfoundation.org/ Cutaneous Lymphoma Foundation (formerly MFF)] | * [http://www.clfoundation.org/ Cutaneous Lymphoma Foundation (formerly MFF)] | ||
* {{ClinicalTrials|NCT00106431}} - "A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-Cell Lymphoma" | * {{ClinicalTrials|NCT00106431}} - "A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-Cell Lymphoma" |
Revision as of 19:08, 17 September 2012
For patient information, click here
Mycosis fungoides | |
ICD-10 | C84.0 |
---|---|
ICD-9 | 202.1 |
ICD-O: | 9700/3 |
OMIM | 254400 |
DiseasesDB | 8595 |
MeSH | D009182 |
Mycosis fungoides Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mycosis fungoides On the Web |
American Roentgen Ray Society Images of Mycosis fungoides |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Classification
Historical Perspective
Pathophysiology
Epidemiology & Demographics
Risk Factors
Screening
Causes
Differentiating Mycosis fungoides from other Diseases
Natural History, Complications & Prognosis
Diagnosis
History & Symptoms | Physical Examination | Staging | Lab Tests | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention
Related chapters
Resources
- Cutaneous Lymphoma Foundation (formerly MFF)
- Template:ClinicalTrials - "A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-Cell Lymphoma"